Cargando…

Treatment of grey zone lymphoma using the R-CODOX-M/R-IVAC protocol: Two case reports

RATIONALE: We report our experience with 2 patients diagnosed with grey zone lymphoma (GZL). The histopathological characteristics of lymphomatous tissues in these patients ranged between those of diffuse large B-cell lymphoma (DLBCL) and the classical Hodgkin lymphoma. PATIENT CONCERNS: A 52-year-o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiao-Yan, Jiang, Ling, Jia, Rong-Fei, Hou, An-Ji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626284/ https://www.ncbi.nlm.nih.gov/pubmed/28953641 http://dx.doi.org/10.1097/MD.0000000000008121

Ejemplares similares

Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
por: Chen, Meiting, et al.
Publicado: (2021)

A Case of Double Expresser Diffuse Large B Cell Lymphoma Treated with R-CODOX-M/R-IVAC
por: Bemis, Thomas, et al.
Publicado: (2019)

HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era
por: Rodrigo, J. A., et al.
Publicado: (2012)

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial()
por: McMillan, A.K., et al.
Publicado: (2020)

Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
por: Noy, Ariela, et al.
Publicado: (2012)

Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial
por: Phillips, Elizabeth H., et al.
Publicado: (2020)

Treatment outcome of diffuse large B-cell lymphoma involving the head and neck: Two-institutional study for the significance of radiotherapy after R-CHOP chemotherapy
por: Kwak, Yoo-Kang, et al.
Publicado: (2017)

Grey Zone Lymphomas: Lymphomas with Intermediate Features
por: Hoeller, Sylvia, et al.
Publicado: (2012)

Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma
por: Luo, Yi-Huan, et al.
Publicado: (2017)

Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening
por: Xu, Hang, et al.
Publicado: (2015)

The Grey Zones of Classic Hodgkin Lymphoma
por: Bosch-Schips, Jan, et al.
Publicado: (2022)

Prognostic potential of miR-144 in various cancers: A meta-analysis
por: Jia, Chong-Yang, et al.
Publicado: (2022)

T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report
por: Shao, Yajuan, et al.
Publicado: (2018)

Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report
por: Cerchione, Claudio, et al.
Publicado: (2020)

Expression of miR-92a is associated with the prognosis in non-small cell lung cancer: An observation study
por: Huang, Yu-Fang, et al.
Publicado: (2022)

Plasma miR-32 levels in non-small cell lung cancer patients receiving platinum-based chemotherapy can predict the effectiveness and prognosis of chemotherapy
por: Xu, Shuyuan, et al.
Publicado: (2019)

MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer
por: Meng, Wen-Jian, et al.
Publicado: (2015)

A case report on the effect of rituximab on pyothorax-associated lymphoma
por: Wang, Fei, et al.
Publicado: (2019)

A Rare Case of Grey Zone Lymphoma Successfully Treated with Brentuximab Vedotin and R-CHP Chemotherapy
por: Mallipudi, Rajiv M., et al.
Publicado: (2019)

Downregulated miR-45 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer
por: Wang, Lan, et al.
Publicado: (2015)

Lymphoma of the central nervous system originating from the septum pellucidum region: Two case reports with literature review
por: Chen, Dawei, et al.
Publicado: (2023)

Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China
por: Zhao, Jiuda, et al.
Publicado: (2016)

Both plasma and tumor tissue miR-146a high expression correlates with prolonged overall survival of surgical patients with intrahepatic cholangiocarcinoma
por: Zhang, Ri-Xin, et al.
Publicado: (2017)

Analysis of genomic alterations in primary central nervous system lymphoma
por: He, Xin, et al.
Publicado: (2023)

Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer
por: Bi, Cheng-wei, et al.
Publicado: (2019)

Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis
por: Hu, Lixia, et al.
Publicado: (2021)

The clinical validity of miR-126 as a prognostic marker in epithelial ovarian cancer
por: Liu, Lin, et al.
Publicado: (2023)

Primary spinal mucosa-associated lymphoid tissue lymphoma: A case report
por: Dong, Rongrong, et al.
Publicado: (2018)

Hsa_circ_0074491 regulates the malignance of cholesteatoma keratinocytes by modulating the PI3K/Akt pathway by binding to miR-22-3p and miR-125a-5p: An observational study
por: Hu, Yunlong, et al.
Publicado: (2021)

Pulmonary Extranodal Natural Killer/T-Cell Lymphoma (Nasal Type): A Case Report and Radiological Image Review
por: Fei, Wang, et al.
Publicado: (2015)

Treatment of refractory MALT lymphoma by lenalidomide plus bendamustine: A case report
por: Zhou, Zhencang, et al.
Publicado: (2022)

Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2
por: Ding, Zhenhua, et al.
Publicado: (2015)

Association between polymorphism near the MC4R gene and cancer risk: A meta-analysis
por: Zeng, Tian, et al.
Publicado: (2020)

Rare primary pulmonary mucosa-associated lymphoid tissue lymphoma misdiagnosed with tuberculosis: A case report
por: Gu, Min, et al.
Publicado: (2023)

Association of miR-4293 rs12220909 polymorphism with cancer risk: A meta-analysis of 8394 subjects
por: Liu, Rongqiang, et al.
Publicado: (2020)

The impact of miR-9 in osteosarcoma: A study based on meta-analysis, TCGA data, and bioinformatics analysis
por: Wu, Fengfeng, et al.
Publicado: (2020)

Synchronous diffuse large B-cell lymphoma of the stomach and small cell lung carcinoma: A case report
por: Li, Jia, et al.
Publicado: (2017)

Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review
por: Lin, Li, et al.
Publicado: (2017)

CAV1 rs7804372 (T29107A) polymorphism might be a potential risk for digestive cancers: A protocol for systematic review and meta analysis
por: Chen, Pei, et al.
Publicado: (2021)

Multifocal extranodal lymphoma: A case report
por: Li, Chao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cru5gcmgbebl7678p0titjc2g1